Kynurenines in the CNS: from endogenous obscurity to therapeutic importance

被引:271
作者
Stone, TW [1 ]
机构
[1] Univ Glasgow, Inst Biomed & Life Sci, Glasgow G12 8QQ, Lanark, Scotland
关键词
kynurenine; kynurenic acid; quinolinic acid; tryptophan; neurodegeneration; neuroprotection; excitotoxicity;
D O I
10.1016/S0301-0082(00)00032-0
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
In just under 20 years the kynurenine family of compounds has developed from a group of obscure metabolites of the essential amino acid tryptophan into a source of intensive research. with postulated roles for quinolinic acid in neurodegenerative disorders, most especially the AIDS-dementia complex and Huntington's disease. One of the kynurenines, kynurenic acid, has become a standard tool for use in the identification of glutamate-releasing synapses, and has been used as the parent for several groups of compounds now being developed as drugs for the treatment of epilepsy and stroke. The kynurenines represent a major success in translating a basic discovery into a source of clinical understanding and therapeutic application, with around 3000 papers published on quinolinic acid or kynurenic acid since the discovery of their effects in 1981 and 1982. This review concentrates on some of the recent work most directly relevant to the understanding and applications of kynurenines in medicine. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:185 / 218
页数:34
相关论文
共 347 条
[1]  
Achim C L, 1996, J NeuroAIDS, V1, P1, DOI 10.1300/J128v01n02_01
[2]   Expression of the kynurenine enzymes in macrophages and microglial cells: regulation by immune modulators [J].
Alberati-Giani, D ;
Cesura, AM .
AMINO ACIDS, 1998, 14 (1-3) :251-255
[3]  
AlberatiGiani D, 1996, J NEUROCHEM, V66, P996
[4]   Increased kynurenic acid levels and decreased brain kynurenine aminotransferase I in patients with down syndrome [J].
Baran, H ;
Cairns, N ;
Lubec, B ;
Lubec, G .
LIFE SCIENCES, 1996, 58 (21) :1891-1899
[5]   Kynurenine metabolism in Alzheimer's disease [J].
Baran, H ;
Jellinger, K ;
Deecke, L .
JOURNAL OF NEURAL TRANSMISSION, 1999, 106 (02) :165-181
[6]   Temporal and spatial changes of quinolinic acid immunoreactivity in the gerbil hippocampus following transient cerebral ischemia [J].
Barattè, S ;
Molinari, A ;
Veneroni, O ;
Speciale, C ;
Benatti, L ;
Salvati, P .
MOLECULAR BRAIN RESEARCH, 1998, 59 (01) :50-57
[7]  
BARON BM, 1990, MOL PHARMACOL, V38, P554
[8]  
BARON BM, 1992, J PHARMACOL EXP THER, V262, P947
[9]   THE RELATIONSHIP BETWEEN PLASMA AND BRAIN QUINOLINIC ACID LEVELS AND THE SEVERITY OF HEPATIC-ENCEPHALOPATHY [J].
BASILE, AS ;
SAITO, K ;
ALMARDINI, H ;
RECORD, CO ;
HUGHES, RD ;
HARRISON, P ;
WILLIAMS, R ;
LI, Y ;
HEYES, MP .
GASTROENTEROLOGY, 1995, 108 (03) :818-823
[10]  
BASILE AS, 1995, J NEUROCHEM, V64, P2607